Crinetics Pharmaceuticals (CRNX) CEO exercises stock options for 19,928 shares
Rhea-AI Filing Summary
Crinetics Pharmaceuticals, Inc. reported that President & CEO Richard Scott Struthers exercised stock options on August 7, 2026 to acquire a total of 19,928 shares of common stock through four option exercises. The options had exercise prices of $25.19, $22.61, $20.02, and $15.29 per share. Indirect holdings include common stock held by multiple family trusts and a charitable trust, with examples such as 136,805 shares held by Family Trust 1 and 80,000 shares held by a Charitable Trust. No sales of common stock are reported in this filing.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 19,928 shares
Net Buy
18 txns
Insider
Struthers Richard Scott
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 3,969 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F2 | 4,422 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F3 | 6,542 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F4 | 4,995 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,969 | $25.19 | $100K |
| Exercise | Common Stock | 4,422 | $22.61 | $100K |
| Exercise | Common Stock | 6,542 | $15.29 | $100K |
| Exercise | Common Stock | 4,995 | $20.02 | $100K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 871,122 shares (Direct);
Common Stock — 424,706 shares (Direct);
Common Stock — 136,805 shares (Indirect, By Family Trust 1);
Common Stock — 106,000 shares (Indirect, By Family Trust 2);
Common Stock — 110,000 shares (Indirect, By Family Trust 3);
Common Stock — 100,000 shares (Indirect, By Family Trust 4);
Common Stock — 111,100 shares (Indirect, By Family Trust 5);
Common Stock — 111,100 shares (Indirect, By Family Trust 6);
Common Stock — 111,100 shares (Indirect, By Family Trust 7);
Common Stock — 111,100 shares (Indirect, By Family Trust 8);
Common Stock — 1,000 shares (Indirect, By Spouse);
Common Stock — 80,000 shares (Indirect, By Charitable Trust)
Footnotes (4)
- F1. 1/48th of the shares subject to the option vested monthly.
- F2. 1/48th of the shares subject to the option vested on March 24, 2020, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
- F3. 1/48th of the shares subject to the option vested on March 26, 2021, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
- F4. 1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Key Figures
Total shares acquired via option exercise: 19,928 shares
Option exercise price: $25.19 per share
Option exercise price: $22.61 per share
+5 more
8 metrics
Total shares acquired via option exercise
19,928 shares
Exercise of stock options into common stock on August 7, 2026
Option exercise price
$25.19 per share
Stock Option (Right to Buy) exercised for 3,969 underlying common shares
Option exercise price
$22.61 per share
Stock Option (Right to Buy) exercised for 4,422 underlying common shares
Option exercise price
$15.29 per share
Stock Option (Right to Buy) exercised for 6,542 underlying common shares
Option exercise price
$20.02 per share
Stock Option (Right to Buy) exercised for 4,995 underlying common shares
Indirect holding Family Trust 1
136,805 shares
Common stock held indirectly by Family Trust 1 after the reported date
Indirect holding Charitable Trust
80,000 shares
Common stock held indirectly by a Charitable Trust
Indirect holding by spouse
1,000 shares
Common stock reported as indirectly owned by spouse
Key Terms
Stock Option (Right to Buy), Common Stock, Family Trust, Charitable Trust, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for derivative entries"
Common Stock financial
"underlying_security_title and security_title fields list "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Family Trust financial
"nature_of_ownership includes "By Family Trust 1" through "By Family Trust 8""
Charitable Trust financial
"nature_of_ownership shows indirect ownership "By Charitable Trust""
indirect ownership financial
"ownership_type "indirect" and ownership_code "I" denote indirect ownership"
vesting financial
"footnotes describe that 1/48th of the shares subject to the option vested monthly"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did CRNX CEO Richard Scott Struthers report in this Form 4?
He reported exercising stock options to acquire 19,928 shares of Crinetics common stock on August 7, 2026, through four separate option exercises at exercise prices ranging from $15.29 to $25.19 per share, with no stock sales reported.
How many Crinetics (CRNX) options did the CEO exercise and at what prices?
He exercised options covering 19,928 shares of common stock. The underlying options had exercise prices of $25.19, $22.61, $20.02, and $15.29 per share, each tied to separate grants that vested monthly over time.
What indirect CRNX holdings does the CEO report through family trusts?
He reports indirect ownership of common stock through several family trusts, including 136,805 shares held by Family Trust 1 and 106,000 shares by Family Trust 2, plus additional stakes in other named family trusts and a charitable trust.
Does the Crinetics (CRNX) Form 4 involve a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox is not checked, and no footnote indicates a trading plan. The reported option exercises on August 7, 2026 therefore are not identified in the filing as occurring under a pre-arranged Rule 10b5-1 plan.
What vesting terms applied to the CRNX stock options exercised by the CEO?
Footnotes state that 1/48th of each option grant vested monthly, with initial vesting dates in March 2020, 2021, and 2022. Continued vesting was subject to the reporting person’s continued employment with Crinetics on each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
